Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Zika Virus Infection, January 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 152 articles: HTML format

Single Articles

1. OOI EE
   Zika immune imprint risks dengue.
   Nat Immunol. 2026 Jan 2. doi: 10.1038/s41590-025-02365.
   Abstract
   
   
2. CARDONA-OSPINA JA, Roy V, Marcano-Jimenez DE, Bos S, et al
   IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans.
   Nat Immunol. 2026 Jan 2. doi: 10.1038/s41590-025-02363.
   Abstract
   
   
3. DHAR R, Singh S, Sahoo OS, Chandra N, et al
   The placental battlefield: viral strategies and immune countermeasures.
   Front Immunol. 2025;16:1667601.
   Abstract
   
   
4. PIMENTA JC, Pereira JAB, Teixeira DC, da Silva Santos FR, et al
   Methods for Evaluating Neurotropic Viral Infections: Exploring Zika and Coronavirus Diseases.
   Methods Mol Biol. 2026;2993:215-264.
   Abstract
   
   
5. BATISTA VL, Martins JR, Teixeira DC, Pereira JAB, et al
   Platforms to Evaluate Flavivirus-Induced Immunoinflammatory Responses and Their Pathogenesis.
   Methods Mol Biol. 2026;2993:195-213.
   Abstract
   
   
6. LIMA LR, Mustafa YM, Fonseca PLC, Coelho SVA, et al
   Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo.
   Front Cell Infect Microbiol. 2025;15:1726007.
   Abstract
   
   
7. LIMA LR, Mustafa YM, Fonseca PLC, Coelho SVA, et al
   Correction: Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo.
   Front Cell Infect Microbiol. 2025;15:1762181.
   Abstract
   
   
8. SHENOY DR, Ananthanarayanan R, Niyas VKM, R V, et al
   Zika Virus Disease in Pregnancy: A Case Series from the Kerala Outbreak.
   J Obstet Gynaecol India. 2025;75:517-520.
   Abstract
   
   
9. OLIVEIRA HFV, Rego FRQ, Cavalcanti BS, Bacellar IR, et al
   [Reply to the Letter to the Editor Regarding "Description of Hip Deformities in 5-Year-Old Patients with Congenital Zika Virus Syndrome: A Cross-Sectional Study"].
   Rev Bras Ortop (Sao Paulo). 2025;60:s00451814119.
   Abstract
   
   
10. OLIVEIRA HFV, Rego FRQ, Cavalcanti BS, Bacellar IR, et al
    Reply to the Letter to the Editor Regarding "Description of Hip Deformities in 5-Year-Old Patients with Congenital Zika Virus Syndrome: A Cross-Sectional Study".
    Rev Bras Ortop (Sao Paulo). 2025;60:s00451814118.
    Abstract
    
    
11. KLEEBAYOON A, Wiwanitkit V
    Description of Hip Deformities in 5-Year-Old Patients with Congenital Zika Virus Syndrome.
    Rev Bras Ortop (Sao Paulo). 2025;60:s00451814120.
    Abstract
    
    
12. KLEEBAYOON A, Wiwanitkit V
    [Description of Hip Deformities in 5-Year-Old Patients with Congenital Zika Virus Syndrome].
    Rev Bras Ortop (Sao Paulo). 2025;60:s00451814121.
    Abstract
    
    
13. CALDERON-PELAEZ MA, Velandia-Romero ML, Castellanos JE
    In vivo and in vitro susceptibility and inflammatory response of postnatal mouse cortical neurons and glial cells to zika virus infection.
    PLoS One. 2025;20:e0339900.
    Abstract
    
    
14. MENEZES A, Walter-Nuno AB, Costa-Bartuli E, Moreira D, et al
    A diet-induced obese and diabetic host phenotype reduces mosquito ZIKV infections and remodels gut metabolism.
    Front Immunol. 2025;16:1704301.
    Abstract
    
    
15. LIU Y, Zhang J, Zhu J, Ni H, et al
    Generation of a Human-Mouse Chimeric Anti-Japanese Encephalitis Virus and Zika Virus Monoclonal Antibody Using CDR Grafting.
    Microorganisms. 2025;13:2868.
    Abstract
    
    
16. BALAKRISHNAN B, Arul SS, Ravindran A, Venkataraman S, et al
    Competitive Viral Interference Controls Arbovirus Co-Transmission in Aedes aegypti.
    Sci Rep. 2025;15:45679.
    Abstract
    
    
17. LEE YJ, Kang N, Heo JH, Kim EA, et al
    Antiviral Activity of Ethyl Gallate Against Zika Virus: In Vitro and In Silico Studies.
    Int J Mol Sci. 2025;26:12062.
    Abstract
    
    
18. MIRANDA-FILHO DB, Ximenes RAA, Ramos Montarroyos U, Rosa Abtibol-Bernardino M, et al
    Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium.
    PLOS Glob Public Health. 2025;5:e0005425.
    Abstract
    
    
19. TAMAYO-MOLINA YS, Garcia-Marin Y, Urcuqui-Inchima S
    2-Deoxy-D-glucose attenuates lipopolysaccharide-induced inflammation and restricts Zika, Chikungunya, and Mayaro virus replication in monocyte-derived macrophages.
    Antiviral Res. 2025;246:106338.
    Abstract
    
    
20. VIDAL HDA, Mesquita NCMR, Bernardes ACB, Mourao PS, et al
    Fragment-based discovery and optimization of Zika virus NS3 helicase ligands as antiviral hit candidates.
    Eur J Med Chem. 2025;304:118521.
    Abstract
    
    
21. SANOU AM, Nikiema AS, Sausy A, Diendere J, et al
    Serologic Evidence of Circulation of Six Arboviruses (Dengue Virus, Chikungunya Virus, Zika Virus, Rift Valley Virus, Yellow Fever Virus, Crimean-Congo Hemorrhagic Fever Virus) in Four Regions of Burkina Faso, West Africa.
    Trop Med Infect Dis. 2025;10:345.
    Abstract
    
    
22. SHARIFF Y, Malik MA, Abbas M
    Congenital Zika Syndrome Presenting With Late-Onset Seizures: A New Phenotypic Variant.
    Pediatr Infect Dis J. 2025 Dec 24. doi: 10.1097/INF.0000000000005126.
    Abstract
    
    
23. ABISI HK, Ghezzi S, Pagani I, Vicenzi E, et al
    In vitro Control of RNA Virus Infections by M1-Polarized Human Monocyte-Derived Macrophages.
    New Microbiol. 2025;48:287-292.
    Abstract
    
    
24. WANG Y, Galkin A, Shang X, Marin A, et al
    Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk.
    Nat Commun. 2025;16:11558.
    Abstract
    
    
25. SMITH AJ, Rahat MA, Scaramozza LJ, Eyles SJ, et al
    Inhibition of Zika Virus Protease by Modulating NS2B-NS3 Interactions.
    Biochemistry. 2025 Dec 22. doi: 10.1021/acs.biochem.5c00644.
    Abstract
    
    
26. ADIA NAB, Shah PS
    Image-based morphological profiling of autophagy phenotypes in Zika virus infected cells.
    bioRxiv [Preprint]. 2025 Dec 11:2025.12.09.693313.
    Abstract
    
    
27. GUIMARAES-ANDRADE IP, Barboza RS, da Silva MOL, da Conceicao RA, et al
    Bioactive Flavanone Glycoside Isolated from Leaves of Faramea Species Presents Antiviral and Protective Activity against Zika and Mayaro Virus Infection.
    ACS Omega. 2025;10:60196-60204.
    Abstract
    
    
28. ROBIN P, Gerber-Lemaire S
    Assessment of Hairpin-Functionalization of Gold Nanoparticles toward a Facile Detection of Zika Virus and Lineage Identification.
    ACS Omega. 2025;10:60900-60911.
    Abstract
    
    
29. ZHENG X, Yan X, Xu X, Heng L, et al
    Preliminary survey of dengue, Zika and chikungunya viruses by nucleic acid test in blood donors in Shenzhen, China.
    Front Public Health. 2025;13:1672814.
    Abstract
    
    
30. RICHARDSON RB, Kikawa C, Garg A, Bednarski E, et al
    Coevolutionary constraints of Zika virus nonstructural protein 5 replication and interferon antagonism activities.
    bioRxiv [Preprint]. 2025 Dec 23:2025.12.23.696258.
    Abstract
    
    
31. FALCAO DE OLIVEIRA E, Carvalho AT, Venancio FA, Quiliao ME, et al
    Zika virus infection in early pregnancy increases the likelihood of persistent neutralizing antibodies.
    PLoS Negl Trop Dis. 2026;20:e0013906.
    Abstract
    
    
32. KIM J, Lee W, Kim DY, Ku KB, et al
    Brain-infiltrating CD8 T cells retain functional activity to protect against acute Zika virus infection.
    Sci Rep. 2026 Jan 5. doi: 10.1038/s41598-026-35079.
    Abstract
    
    
33. RODRIGUES T, Beltrao GS, Girardi H, Pinto AR, et al
    Viral reprogramming of glial metabolism as a driver of neuroinflammation.
    Front Immunol. 2025;16:1686774.
    Abstract
    
    
34. SUN X, Jiang H, Yu W, Wang N, et al
    Multivalent display of Envelope protein domain III with Mi3 nanoparticles induces protective immunity against lethal Zika virus infection in mice.
    Virol Sin. 2026 Jan 2:S1995-820X(25)00192-0. doi: 10.1016/j.virs.2025.
    Abstract
    
    
35. BRAZ-DE-MELO HA, Lago FG, Correa R, Santos IO, et al
    Zika Virus Reprograms Microglial Mitochondrial Metabolism to Support Immune Activation and Viral Replication: Omega-3 DHA Counteracts Neuroinflammation and Viral Persistence.
    Mol Neurobiol. 2026;63:341.
    Abstract
    
    
36. IZABAYO P, Hakizimana JC, Uwineza A, Alagbonsi AI, et al
    Environmental factors associated with microcephaly in Africa: A systematic review.
    Neurotoxicol Teratol. 2026;113:107577.
    Abstract
    
    
37. DE OLIVEIRA JHP, Arruda IES, de Sena Junior MR, de Oliveira FHC, et al
    Beyond DALY: public funding of health innovation in Brazil as a political strategy for equity in the Global South.
    BMC Public Health. 2025;26:56.
    Abstract
    
    
38. PLENTZ I, Pazzin D, Previato T, Wagner F, et al
    Influence of IgG+ serum on Zika virus infection response in a model of neural precursor cells.
    Biochem Biophys Rep. 2025;44:102260.
    Abstract
    
    
39. MOURA LG, Ianni AMZ
    [The technoscientific production of zika virus and zika disease: risks and insecurity in the health field].
    Hist Cienc Saude Manguinhos. 2026;32:e2025058.
    Abstract
    
    
40. GRECO LF, da Silva RGL, de Campos AS, da Costa JP, et al
    'Well... we keep adapting our labs': Interconnected factors shaping vaccine R&D and production capacity in Brazil.
    Glob Public Health. 2026;21:2614156.
    Abstract
    
    
41. PEREIRA RS, Campana PRV, Costa VV, Maltarollo VG, et al
    Bioactivity-Guided Isolation of beta-Sitosterol From Terminalia glabrescens as a Potent Anti-Zika Virus Agent.
    Chem Biodivers. 2026;23:e02860.
    Abstract
    
    
42. AZEVEDO LMS, Rios DL, Diniz LNA, de Oliveira SN, et al
    Effect of antibody-dependent enhancement on the development of the offspring of mice infected by Zika virus: Analysis of the brain transcriptome.
    Microb Pathog. 2026;212:108292.
    Abstract
    
    
43. SCIRE EM, Huang AL, Boccia T, Kycia I, et al
    Transamniotic Fetal mRNA Vaccination: Active Immunization Against Zika Virus in a Rodent Model.
    J Pediatr Surg. 2026 Jan 9:162922. doi: 10.1016/j.jpedsurg.2026.162922.
    Abstract
    
    
44. CHEN XZ, Gong YX, Guo HX, He JX, et al
    Study on the spatiotemporal regulation of interferon-stimulated genes during Zika virus infection.
    Front Immunol. 2026;16:1702266.
    Abstract
    
    
45. CAMPBELL H, Morris TP, Gustafson P
    A Fully-Integrated Bayesian Approach for the Imputation and Analysis of Derived Outcome Variables With Missingness.
    Stat Med. 2026;45.
    Abstract
    
    
46. BRITO ASS, Meira CAC, Moreira KMA, Santino TA, et al
    Sensorial function in children with congenital Zika syndrome: what is the relationship with motor function?
    Rev Paul Pediatr. 2026;44:e2025112.
    Abstract
    
    
47. MARQUINE S, Mura M, de Laval F, Grard G, et al
    Longitudinal Monitoring of Systemic Cytokines After Mild Zika Virus Infection Revealed an Association Between Th17 Polarization and Clinical and Serological Outcomes.
    J Med Virol. 2026;98:e70813.
    Abstract
    
    
48. HUANG YL, Chen HM, He HW, Lu ZH, et al
    A Point-of-Care Platform for Simultaneous Triplex PCR Detection of Chikungunya, Dengue, and Zika Virus Infections.
    J Vis Exp. 2025;.
    Abstract
    
    
49. MARTIN H, Martin C, Guimbaud L, Duchanois D, et al
    Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface.
    J Vis Exp. 2025;.
    Abstract
    
    
50. SANTOS R, Mekonnen ZA, Yeow AEL, Whelan DM, et al
    Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus.
    NPJ Vaccines. 2026 Jan 17. doi: 10.1038/s41541-025-01356.
    Abstract
    
    
51. CHOU TW, McCourt M, Marmut E, Karuppusamy V, et al
    Inapparent maternal ZIKV infection impacts fetal brain development and postnatal behavior.
    PLoS Pathog. 2026;22:e1013850.
    Abstract
    
    
52. HUAI Y, Wang X, Yan J, Li S, et al
    Emerging viroporins, RBP dynamics, and skeletal remodeling: Targeting liquid-liquid phase separation for dual antiviral and bone-protective therapies.
    Mol Aspects Med. 2026;107:101445.
    Abstract
    
    
53. BURCIAGA-FLORES M, Wong-Romero J, Elizondo-Quiroga D, Villalobos-Sanchez E, et al
    Discovery and computational characterization of ZIKV envelope-targeted peptides from a subtractive phage display library.
    PLoS One. 2026;21:e0341602.
    Abstract
    
    
54. AUSDERAU KK, Boerigter B, Razo ER, Gutkes J, et al
    Prenatal Zika virus exposure disrupts social-emotional development and cortical visual function in infant macaques.
    Nat Commun. 2026 Jan 29. doi: 10.1038/s41467-026-68517.
    Abstract
    
    
55. HUANG MS, Liao HC, Peng P, Wu WL, et al
    Non-Targeting shRNA-Encoded Plasmid DNA Enhances Protective Immunity Through RIDD-RIG-I Signaling Pathway in the Zika Virus Animal Model.
    Adv Sci (Weinh). 2026 Jan 28:e17420. doi: 10.1002/advs.202517420.
    Abstract
    
    
56. LEAL LRS, de Sena MGAM, Invencao MDCV, de Moura IA, et al
    Development and Immunogenicity Assessment of a Multi-Epitope Antigen Against Zika Virus: An In Silico and In Vivo Approach.
    Vaccines (Basel). 2025;14:31.
    Abstract
    
    
57. DA SILVA PONE MV, Pone SM
    Zika Virus and Congenital Zika Syndrome: Special Issue Editorial.
    Viruses. 2026;18:80.
    Abstract
    
    
58. VAJO Z, Laszlofy C
    Preparing for the Next Potential Pandemic-Chikungunya, Dengue, Zika and Other Viruses.
    Viruses. 2025;18:37.
    Abstract
    
    
59. STARVAGGI J, Di Chio C, Lang J, Belgiovine V, et al
    Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease.
    Pharmaceuticals (Basel). 2025;19:24.
    Abstract
    
    
60. ROOZITALAB A, Zhang C, Zhang J, Li G, et al
    About Zika Virus (ZIKV). Reply to Weidmann et al. Zika Virus Pathogenicity Versus Transmissibility. Comment on "Roozitalab et al. Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry
    Pathogens. 2026;15:68.
    Abstract
    
    
61. WEIDMANN M, Faye O, Faye M
    Zika Virus Pathogenicity Versus Transmissibility. Comment on Roozitalab et al. Distinct Virologic Properties of African and Epidemic Zika Virus Strains: The Role of the Envelope Protein in Viral Entry, Immune Activation, and Neuropathogenesis. Pathoge
    Pathogens. 2026;15:67.
    Abstract
    
    
62. DUTTA A, Sanin KI, Sharaque AR, Elahi M, et al
    Seroprevalence of Dengue, Chikungunya, and Zika Viruses Among Febrile Patients in Dhaka, Bangladesh: A Hospital-Based Cross-Sectional Study.
    Pathogens. 2025;15:31.
    Abstract
    
    
63. TRAORE S, Chima SC, Adams Waldorf KM, Tisoncik-Go J, et al
    Evaluating the pandemic potential of Zika virus in a changing global landscape.
    Curr Opin Immunol. 2026;99:102724.
    Abstract
    
    
64. RONGIOLETTI F, Drago F
    Cutaneous Manifestations of Emerging Arbovirus Infections Including West Nile, Dengue, Zika, Chikungunya, Usutu, and Toscana Viruses: A Clinical Overview for Dermatologists.
    Am J Clin Dermatol. 2026 Jan 24. doi: 10.1007/s40257-025-01000.
    Abstract
    
    
65. DESJARDINS MR, Casas I, Victoria-Castro AM, Hammelman C, et al
    Utilizing perceptions of public health officials in Cali, Colombia to support the surveillance of co-circulating vector-borne diseases.
    Soc Sci Med. 2026;391:118890.
    Abstract
    
    
66. WEI YL, Wu Z, Li RL, Tang F, et al
    Review of selected mosquito-borne diseases: arboviruses (dengue, chikungunya, Zika, West Nile, Japanese encephalitis, yellow fever) and parasitic diseases (malaria, lymphatic Filariasis).
    Front Public Health. 2026;13:1712094.
    Abstract
    
    
67. LAI M, Lai R, He B, Li B, et al
    IFI44 Functions as a Positive Regulator of Type I Interferon Signaling to Restrict Zika Virus Infection.
    J Med Virol. 2026;98:e70827.
    Abstract
    
    
68. ELBAMTARI F, Belghalia E, Zaki K, Alaqarbeh M, et al
    Computational investigation of medicinal plants' active ingredient effects as a potential Zika virus treatment: molecular docking, molecular dynamics simulations, ADMET screening, and DFT.
    J Mol Model. 2026;32:61.
    Abstract
    
    
69. LI Z, Xing Y, Huang X, Tian B, et al
    NRZ complex facilitates virus infection via enhancing ER-LD contacts.
    J Cell Biol. 2026;225:e202506149.
    Abstract
    
    
70. KOPPAD M, Shivakumaraswamy SK, Goolappa PT, Mahabaleswara MT, et al
    First report of laboratory-confirmed Zika virus infection in human from South Karnataka, India: A case study.
    J Virol Methods. 2026;342:115357.
    Abstract
    
    
71. MAXWELL L, Shreedhar P, Merson L, Levis B, et al
    How to conduct an individual participant data meta-analysis in response to an emerging pathogen: Lessons learned from Zika and COVID-19.
    Res Synth Methods. 2026;17:1-29.
    Abstract
    
    
72. AURELIO B, Kaisar MMM, Wijaya V, Khustiawan SOR, et al
    A Systematic Review and Meta-Analysis of Global DENV, CHIKV, and ZIKV Co-Infection.
    Rev Med Virol. 2026;36:e70108.
    Abstract
    
    
73. BUCHER BT, Kunisaki SM
    Invited Commentary on "Transamniotic Fetal mRNA Vaccination: Active Immunization Against Zika Virus in a Rodent Model".
    J Pediatr Surg. 2026 Jan 28:162950. doi: 10.1016/j.jpedsurg.2026.162950.
    Abstract
    
    
74. FARRAR DS, Knowles RL, Nunez C, Baynam G, et al
    Etiology of Severe Microcephaly in Infants: A Multinational Surveillance Study.
    Pediatrics. 2026 Jan 21:e2025072700. doi: 10.1542/peds.2025-072700.
    Abstract
    
    
75. LOEANURIT N, Phan TH, Hengphasatporn K, Chanachanvong T, et al
    Chlorinated bis-4-hydroxycoumarins suppress flavivirus replication by inhibiting dengue virus type 2 translation and replication.
    Sci Rep. 2026;16:5300.
    Abstract
    
    
76. GREINER R
    "I'm not moving from here until you resolve this for me": mothers of disabled children overcoming barriers to health care.
    Soc Sci Med. 2026;392:118954.
    Abstract
    
    
77. NGUYEN TTN, Tun MMN, Vu TBH, Nguyen TTT, et al
    Implications of Immune Responses to DENV, JEV, and ZIKV Infections for Cross-Reactivity and Considerations for Vaccine Evaluation.
    Virus Res. 2026 Jan 8:199689. doi: 10.1016/j.virusres.2026.199689.
    Abstract
    
    
78. KROKOVSKY L, Lins CRB, Guedes DRD, da Luz Wallau G, et al
    Dissecting Zika virus transmission by Aedes aegypti and Culex quinquefasciatus mosquitoes to a vertebrate host and its coinfection with Mayaro virus.
    Front Microbiol. 2026;16:1724153.
    Abstract
    
    
79. PONNIAH C, Surya W, Torres J
    Zika NS2B Protein: In Vitro Formation of Large Multimeric Networks.
    Int J Mol Sci. 2026;27:1504.
    Abstract
    
    
80. MIZANUR R, Ayaz KF, Nazmul H, Rahim R, et al
    Reported circulation of Zika and re-circulation of Chikungunya in Dengue-endemic Dhaka, Bangladesh in 2024.
    PLoS One. 2026;21:e0340119.
    Abstract
    
    
81. DANG BN, Kikuta K, Fuller T, Brasil P, et al
    Cardiac findings in infants with in utero exposure to Zika virus - a follow up longitudinal study.
    PLoS Negl Trop Dis. 2026;20:e0014009.
    Abstract
    
    
82. CHENG C, Li R, Guan T, Li H, et al
    Cord blood natural killer cell-derived extracellular vesicles inhibit Zika virus infectivity through ITGB2/perforin-mediated envelope disruption in vitro and in vivo.
    Bioact Mater. 2026;60:456-471.
    Abstract
    
    
83. MANSUROGLU Z, Bortolin V, Lambert F, Conquet L, et al
    A sex-biased response of the adult brain to Zika virus infection: from down-regulation of neuronal IRF3 to enhanced pathology in adult female mice.
    Cell Commun Signal. 2026 Feb 11. doi: 10.1186/s12964-026-02719.
    Abstract
    
    
84. RIBEIRO LS, Palacio-Cortes AM, Navarro-Silva MA, Souza IMS, et al
    Entomovirological Surveillance in Aedes (Stegomyia) aegypti Linnaeus, 1762 and Aedes (Stegomyia) albopictus Skuse, 1894 (Diptera, Culicidae) in new housing areas in eastern Maranhao, Brazil.
    Braz J Biol. 2026;85:e298647.
    Abstract
    
    
85. ONTORIA JM, Torrente E, Missineo A, Alli C, et al
    An allosteric inhibitor of the Zika virus NS2B-NS3 protease with oral efficacy in mouse models.
    Nat Commun. 2026;17:1439.
    Abstract
    
    
86. EDARA VV, Freeman S, Sampson M, Moore K, et al
    Mechanisms of disrupted neurodevelopment after Zika virus infection in infancy.
    bioRxiv [Preprint]. 2026 Jan 28:2026.01.26.701807.
    Abstract
    
    
87. DEDLOFF MR, Reinhardt TR, Ropp TF, Rivera-Cardona J, et al
    Interferon lambda signaling to maternal dendritic cells protects against congenital Zika virus infection.
    bioRxiv [Preprint]. 2026 Jan 27:2026.01.25.701624.
    Abstract
    
    
88. TEIXEIRA DC, Campolina-Silva G, Marim FM, Santos FRDS, et al
    PI3Kgamma Pathway Contributes to Neuroinflammation and Neuronal Death Induced by Zika Virus Infection.
    Immunology. 2026 Feb 7. doi: 10.1111/imm.70113.
    Abstract
    
    
89. MANGLA M, Palo S
    Deceptive appearances: Congenital infections simulating genetic syndromes in fetal Pathology.
    J Neonatal Perinatal Med. 2026;19:134-146.
    Abstract
    
    
90. PANTIGNY R, Combe M, Roesch C, Gadea G, et al
    Two technologies, one goal: Developing and evaluating anti-Zika virus NS1 antibodies using phage display and hybridoma technologies for diagnostic applications.
    J Immunol Methods. 2026 Feb 18:114041. doi: 10.1016/j.jim.2026.114041.
    Abstract
    
    
91. RAMIREZ-MEJIA JM, Fernandez GJ, Urcuqui-Inchima S
    Vitamin D Reprograms Non-Coding RNA Networks to Block Zika Virus in Human Macrophages.
    Pathophysiology. 2026;33:15.
    Abstract
    
    
92. HAN X, Du J, Li W, Yang S, et al
    Zika virus and host protein interactions for understanding molecular mechanisms of pathogenesis and therapeutic development.
    Front Cell Infect Microbiol. 2026;16:1754465.
    Abstract
    
    
93. OOTA S, Intharasongkroh D, Saekram W, Suriya P, et al
    Low Prevalence of Zika Virus RNA Among Thai Blood Donors.
    Vector Borne Zoonotic Dis. 2026 Feb 17:15303667261419564.
    Abstract
    
    
94. ZHANG HT, Peng ZY, Xiong JJ, Luo Y, et al
    From virtual screening to animal models: chlorhexidine and indinavir as promising anti-Zika drug candidates.
    Front Cell Infect Microbiol. 2026;15:1699057.
    Abstract
    
    
95. ROCHA C, Mendes-da-Cruz DA, Negroni E, Mouly V, et al
    Zika virus infection disturbs development of human muscle progenitor cells.
    Front Cell Infect Microbiol. 2026;15:1638589.
    Abstract
    
    
96. MENEZES D, Reis CR, Mamede I, Geddes VEV, et al
    Transcriptomic Profile of Glioblastoma Cells Infected with Zika Virus: A Systematic Review and Pathway Analysis.
    Viruses. 2026;18:249.
    Abstract
    
    
97. OLUWASEMOWO OO, Graham ME, Thissen JB, Avila-Herrera A, et al
    Impact of Selenium and Vitamin E Deficiency on Zika Virus Pathogenesis and Immune Response in Mice.
    Viruses. 2026;18:177.
    Abstract
    
    
98. COSTA M, Trischitta P, Barna FM, Sciortino MT, et al
    Protease Inhibitors and Innate Immune Agonists as Antiviral Strategies Against Dengue and Zika Viruses.
    Pathogens. 2026;15:232.
    Abstract
    
    
99. AKRAM MS, Lin C, Riaz R, Luong QXT, et al
    Antiviral Efficacy, Cytotoxicity, Transcriptomics, and Discriminatory Function of 3D8 scFv Against Dengue and Zika Viruses.
    Int J Mol Sci. 2026;27:1806.
    Abstract
    
    
100. LINGEMANN M, McGee TJ, Migliore GS, DeLuca JM, et al
     Sub-neutralizing concentrations of Zika virus IgM monoclonal antibodies reduce IgG-mediated antibody-dependent enhancement of infectivity.
     bioRxiv [Preprint]. 2026 Jan 3:2026.01.03.697490.
     Abstract
     
     
101. CARVALHO ARV, Reis JDE, Ferraz AC, da Silva Menegatto MB, et al
     Unveiling the Molecular Profile and Antiviral Potential of Costus arabicus L. Against Zika Virus.
     Chem Biodivers. 2026;23:e03147.
     Abstract
     
     
102. CASHMAN KS, Mistry AM, Kesarwani A, De Andrade Costa A, et al
     Oncolytic Zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses.
     Neuro Oncol. 2026 Feb 23:noag037. doi: 10.1093.
     Abstract
     
     
103. YUJI SASAZAKI F, Tudella GCN, de Oliveira-Filho EF, Lopes TRR, et al
     Ten years of Zika in Brazil: achievements, challenges and perspectives.
     Virol J. 2026;23:57.
     Abstract
     
     
104. SINGH V, Uddhav AC, Kumar Sah B, Kumar A, et al
     Breaking down barriers in Zika virus research: progressing immune pathogenesis research, international cooperation, and data sharing for preparedness.
     J Neurovirol. 2026 Mar 2. doi: 10.1007/s13365-025-01289.
     Abstract
     
     
105. DESAI D, Ugale N, Bhawalkar J, Tripathy SP, et al
     The Zika vaccine pursuit: Now is it the right time to act?
     Med J Armed Forces India. 2026;82:249-251.
     Abstract
     
     
106. SOUSA JR, Batista Ferro G, Vieira Teixeira L, Silva C, et al
     Expression of Purinergic and Endothelial Activation Markers in Brain Tissue From Fatal Microcephaly Associated With ZIKV.
     Immun Inflamm Dis. 2026;14:e70382.
     Abstract
     
     
107. KHAN A, George M, Pearce I, Modgil V, et al
     Zika virus and male reproductive health: essential updates for andrologists and fertility specialists.
     Basic Clin Androl. 2026;36:7.
     Abstract
     
     
108. THONGON S, Boonarkart C, Sirihongthong T, Jitobaom K, et al
     Fatty acid transporter protein isoform 2 (FATP2) inhibitor lipofermata inhibits Zika virus replication and blocks fatty acid uptake in SH-SY5Y neuroblastoma cell line.
     Microbiol Spectr. 2026 Mar 11:e0214025. doi: 10.1128/spectrum.02140.
     Abstract
     
     
109. ASAGA PM, Omilabu S, Dakul DA
     Dose-dependent immune modulation in arboviral coinfections among febrile patients.
     Front Cell Infect Microbiol. 2026;16:1776905.
     Abstract
     
     
110. HURLBURT NK, Lubow J, Goo L, Pancera M, et al
     Structural basis for antibody cross-neutralization of Dengue and Zika viruses.
     Commun Biol. 2026 Mar 10. doi: 10.1038/s42003-026-09805.
     Abstract
     
     
111. MCCAIN K, Vicco A, Morgenstern C, Rawson T, et al
     A systematic review and meta-analysis of Zika virus epidemiology.
     Nat Health. 2026;1:355-367.
     Abstract
     
     
112. JUN S, Bido-Medina R, Oviedo J, Miches I, et al
     A case-control neuroimaging investigation of chronic Zika virus-infected adults.
     Front Hum Neurosci. 2026;20:1710905.
     Abstract
     
     
113. LIAO Q, Luo YG, Ye JL, Shi ZY, et al
     The influence of natural adaptation of the DCS-PK structure on the replication efficiency of Zika virus.
     Virology. 2026;619:110846.
     Abstract
     
     
114. YIN W, Zhou R, Zhang W, Li Y, et al
     Zika virus entry inhibitors.
     Bioorg Med Chem. 2026;137:118611.
     Abstract
     
     
115. BROWN AJ, Fagre AC, Gilson J, Horton J, et al
     Comparative susceptibility of Old World and New World bat cell lines to Zika virus: Insights into viral replication and inflammatory responses.
     PLoS Negl Trop Dis. 2026;20:e0014065.
     Abstract
     
     
116. GARTNER S, Stomberg P, Pohlmann S, Winkler M, et al
     Development of immortalized Callithrix jacchus kidney cell lines supporting infection with a panel of viruses.
     PLoS One. 2026;21:e0337680.
     Abstract
     
     
117. WALKER SM, Gordon CJ, Tchesnokov EP, Sun L, et al
     1'- and 4'-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases.
     Viruses. 2026;18:257.
     Abstract
     
     
118. HUANG Y, Lu J, Cui S, Zhao S, et al
     MEK1/2 inhibition prevents DENV and ZIKV infection via disrupting the cytoskeletal vimentin cage required for viral replication.
     J Mol Cell Biol. 2026;17:mjaf037.
     Abstract
     
     
119. PEREIRA SS, Andreata-Santos R, de Castro-Amarante MF, Venceslau-Carvalho AA, et al
     Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses.
     Viruses. 2023;15:1936.
     Abstract
     
     
120. ZENG Q, Liu J, Hao C, Zhang B, et al
     Making sense of flavivirus non-strctural protein 1 in innate immune evasion and inducing tissue-specific damage.
     Virus Res. 2023;336:199222.
     Abstract
     
     
121. RATHORE APS, St John AL
     Immune mechanisms of congenital Zika syndrome.
     Sci Immunol. 2026;11:eadz5647.
     Abstract
     
     
122. LAUTHARTE I, Rasul I
     The anatomy of a public health crisis: Household responses over the course of the Zika epidemic in Brazil.
     J Health Econ. 2026;107:103126.
     Abstract
     
     
123. GE X, Zhou GF, Qian W, Wang N, et al
     Anti-zika virus agents and viral RdRp enzymatic inhibitors of derivatives of 5-membered pyrrolo[3,4-b]indol-3(4H)-one and 6-membered pyridazino[4,5-b]indol-4(5H)-one.
     Eur J Med Chem. 2026;309:118734.
     Abstract
     
     
124. JIA Q, Xue L, Yang J, Yang J, et al
     Effect of Preventive Measures and Heterogeneity of Sexual Contacts on Zika virus Transmission.
     Bull Math Biol. 2026;88:56.
     Abstract
     
     
125. MURTA AR, Filgueiras MS, Donateli CP, Thome MS, et al
     Interaction of intrauterine Zika virus exposure on the relationship between body adiposity and dyslipidemia in school-aged children.
     Front Pediatr. 2026;14:1675914.
     Abstract
     
     
126. FAN D, Lin D, Rao J, Guo C, et al
     Adverse Pregnancy Outcomes and Prevalence Associated With Arboviral Infections (Zika, Dengue, and Chikungunya): An Umbrella Review of Systematic Reviews and Meta-Analyses.
     Rev Med Virol. 2026;36:e70137.
     Abstract
     
     
127. ISLAM S, Haque MA, Hossain MS, Amin MA, et al
     Bioinformatics-Guided structural characterization and immunogenicity assessment of multi-epitope vaccine candidates against Zika virus.
     J Genet Eng Biotechnol. 2026;24:100641.
     Abstract
     
     
128. RODRIGUES ASR, Silva PYF, Rodrigues RP, Pinho KGFD, et al
     Clinical, Neuroimaging and Video Electroencephalography Findings in Children With Congenital Zika Syndrome: An Analysis From a Neurorehabilitation Centre.
     Int J Dev Neurosci. 2026;86:e70115.
     Abstract
     
     
129. NGO KH, Lattmann S, Anindita PD, Liew CW, et al
     An inactive Zika NS2B-NS3pro protease construct for investigating allosteric inhibitors.
     J Struct Biol. 2026;218:108314.
     Abstract
     
     
130. MURINEDDU G, Plicanti E, Corona P, Di Marzo C, et al
     Tricyclic Pyrrole-Based Compounds as Zika Virus Inhibitors.
     Int J Mol Sci. 2026;27:2306.
     Abstract
     
     
131. CANDIDA-SILVA HE, Ferreira HRP, Mendonca JA, da Silva RA, et al
     Control and mitigation of dengue and Zika virus transmission in a hospital in Recife, Brazil: a successful experience with an integrated control program against Aedes aegypti.
     Parasit Vectors. 2026 Mar 13. doi: 10.1186/s13071-025-07241.
     Abstract
     
     
132. CASTANEDA CATANA MA, Morrone J, Carlucci MJ, Vasquez CA, et al
     Bovine serum albumin nanoparticles as a long-acting antiviral delivery platform for mycophenolic acid and ribavirin against emerging RNA viruses.
     Int J Biol Macromol. 2026;351:151059.
     Abstract
     
     
133. MA ZH, Wang Y, Hassaan NA, Chu XN, et al
     ZIKV envelope protein is a strong blocker of early directional differentiation in the neural lineage.
     Commun Biol. 2026;9:395.
     Abstract
     
     
134. VON MALTITZ P, van Hilten N, Weil T, Thummaraj T, et al
     Identification and Characterization of an In Silico Designed Membrane-Active Peptide with Antiviral Properties.
     Adv Sci (Weinh). 2026;13:e13911.
     Abstract
     
     
135. KUMAR S, Scott CAP, Xu L, Moore K, et al
     Light Chain Dominant Quaternary Epitope Recognition and IgG3 Switching Drive Broad Dengue and Zika Virus Neutralization.
     bioRxiv [Preprint]. 2026 Mar 19:2026.03.17.712406.
     Abstract
     
     
136. AMARANTE AM, Tirloni L, Koch J, Bormann F, et al
     m (6) A RNA methylation modulates Zika virus infection by regulating serine proteases in Aedes albopictus.
     bioRxiv [Preprint]. 2026 Mar 18:2026.03.16.711780.
     Abstract
     
     
137. DEOLIA P, Singh A, Mubayi A
     Mathematical modeling of sequential Dengue-Zika infections: dynamic insights into antibody-dependent enhancement and neutralization effects.
     Sci Rep. 2026 Mar 24. doi: 10.1038/s41598-026-44242.
     Abstract
     
     
138. MUKHERJEE I, Ferland N, Nguyen KT, Adames SM, et al
     Comparative analysis of placental transmission mechanisms for Dengue and Zika viruses: outcomes and future directions.
     Front Immunol. 2026;17:1749309.
     Abstract
     
     
139. CHOI JW, Song YJ
     Umbelliferone Inhibits Zika Virus (ZIKV) NS5 Activity and Replication In Vitro.
     ACS Omega. 2026;11:16756-16764.
     Abstract
     
     
140. GWEE CP, Felicetti T, Chan KWK, Tan MJA, et al
     Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5'-Terminal Oligopyrimidine Motif-Containing mRNA.
     J Med Chem. 2026;69:7111-7141.
     Abstract
     
     
141. ADU EA, Amuasi JH, Alani H, Wiredu AP, et al
     (Sero)prevalence of (re)emerging major arbovirus infections in Africa: a systematic review and meta-analysis protocol.
     Syst Rev. 2026;15:97.
     Abstract
     
     
142. BONICA MB, Marti GA, Goenaga S, Balsalobre A, et al
     Protocol for experimental infections with viruses in mosquitoes using a glass artificial feeder.
     STAR Protoc. 2025;6:104117.
     Abstract
     
     
143. ZHANG S, Chen D, Zhang K, Liu M, et al
     ZIKV infection causes placental inflammation through activating PANoptosis.
     J Virol. 2025;99:e0175925.
     Abstract
     
     
144. FERDOUS J, Nasif MAO, Cowman G, Muntasir I, et al
     Zika Virus Outbreak - Bangladesh, September-December 2024.
     MMWR Morb Mortal Wkly Rep. 2026;75:1-6.
     Abstract
     
     
145. BACCIN F, Montenegro MA
     Congenital Zika Syndrome.
     N Engl J Med. 2026;394:e2.
     Abstract
     
     
146. SHU B, Ng TS, Lim XN, Zhang S, et al
     An ultrapotent human antibody neutralizes all maturation states of Zika virus.
     Proc Natl Acad Sci U S A. 2025;122:e2502522122.
     Abstract
     
     
147. ROBA A, Kiiru J, Kirui E, Langat P, et al
     Molecular diagnosis of arboviruses (dengue, Chikungunya, yellow fever, Rift Valley fever, Mayaro, West Nile, and Zika viruses) in non-malaria acute febrile illnesses in Kenya's Garissa County, July 2023, and Mombasa County, July 2024.
     BMC Infect Dis. 2026;26:27.
     Abstract
     
     
148. DEL VALLE-MENDOZA J, Watson H, Tarazona-Castro Y, Silva-Caso W, et al
     Temporal cytokine profiling of acute dengue, Zika, Chikungunya, and Mayaro virus infections in Northern Peru.
     BMC Infect Dis. 2026 Jan 17. doi: 10.1186/s12879-026-12537.
     Abstract
     
     
149. VALOTTO RS, Junior PCML, Machado-de-Avila R, Campos FV, et al
     Consensus-based computational mapping of NS1 antigenic determinants in dengue and Zika viruses to improve diagnostic specificity.
     BMC Infect Dis. 2026 Jan 24. doi: 10.1186/s12879-025-12291.
     Abstract
     
     
150. HAUNER A, Benitez AJ, Mulopo-Mukanya N, Roge S, et al
     Technical validation and implementation of a multiplex real-time PCR for differential diagnostic detection of Zika virus, yellow fever virus, dengue virus and chikungunya virus (ZYDC-PCR).
     BMC Infect Dis. 2026 Feb 6. doi: 10.1186/s12879-026-12570.
     Abstract
     
     
151. OLIVEIRA CH, Teixeira TJ, Barros RMC, Araujo AB, et al
     Entomo-virological investigation in urban forest fragments and intradomiciles during a dengue outbreak in Salinas, MG, Brazil.
     Mem Inst Oswaldo Cruz. 2026;120:e250086.
     Abstract
     
     
152. ORTH HM, Meierkord D, Holtfreter MC, Luedde T, et al
     Zika virus infection in a German traveller to the Maldives, August 2025.
     Travel Med Infect Dis. 2026 Feb 23:102960. doi: 10.1016/j.tmaid.2026.102960.
     Abstract